Drug Substance Manufacturing - Mammalian Cell Cultures

Drug Substance Manufacturing - Mammalian Cell Cultures
Product Description

- Fast & tailored transfers - Up- and downstream processing - Large-scale GMP facilities licensed by EMA, FDA & MHLW - Clinical and commercial supply - Launch preparation - Fill & Finish - Quality control & assurance

Boehringer Ingelheim Pharma GmbH & Co.KG

  • DE
  • 2023
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
Specifications
  • Details
    Global network offering late stage and commercial manufacturing of biopharmaceuticals Drug Substance from mammalian cell cultures.

    Produkt Track Record: 


    Biberach, Germany: 
    Vienna, Austria:
  • Model
    CMO

Boehringer Ingelheim Pharma GmbH & Co.KG

  • DE
  • 2023
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO

Boehringer Ingelheim Pharma GmbH & Co.KG resources (2)